Century Therapeutics (IPSC) Depreciation and Depletion (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Depreciation and Depletion data on file, last reported at $3.0 million in Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $3.0 million, down 6.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.9 million (down 3.11% YoY), and the FY2025 annual result was $13.1 million, down 1.53% from the prior year.
• Depreciation and Depletion retreated to $3.0 million in Q1 2026 per IPSC's latest filing, from $3.6 million in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $3.6 million in Q4 2023 and troughed at $1.2 million in Q1 2022.
• A 5-year average of $3.0 million and a median of $3.2 million in 2025 frame the typical range for Depreciation and Depletion.
• The sharpest annual moves came in 2022 and 2025: Depreciation and Depletion soared 170.03% in 2022, then dropped 7.54% in 2025.
• A 5-year view of Depreciation and Depletion shows it stood at $2.8 million in 2022, then advanced by 25.16% to $3.6 million in 2023, then dropped by 6.59% to $3.3 million in 2024, then grew by 6.99% to $3.6 million in 2025, then fell by 15.38% to $3.0 million in 2026.
• Business Quant data shows IPSC's Depreciation and Depletion at $3.0 million in Q1 2026, $3.6 million in Q4 2025, and $3.1 million in Q3 2025.